N-(ピラジニルカルボニル)-L-フェニルアラニン - CAS:114457-94-2

品名:	(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanoic acid
英語別名:	(S)-3-Phenyl-2-(pyrazine-2-carboxamido)propanoic acid;N-(Pyrazinylcarbonyl)-L-phenylalanine;(S)-3-PHENYL-2-[(PYRAZIN-2-YLCARBONYL)AMINO] PROPANOIC ACID;(S)-3-Phenyl-2-[[(pyrazin-2-yl)carbonyl]amino]propanoic acid;L-Phenylalanine,N-(2-pyrazinylcarbonyl)-;N-(2-Pyrazinylcarbonyl)-L-phenylalanine;N-Pyrazinylcarbonyl-;N-Pyrazinylcarbonyl-L-phenylalanine;N-PYRAZINYLCARBONYLPHENYLALANINE;(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoic acid;Bortezomib INT B;Bortezomib impurity B;Bortezomib Impurity 36;Bortezomib Acid Impurity;N-(2-pyrazinylcarbonyl)-;Bortezomib Intermediate 2;(pyrazine-2-carbonyl)-L-phenylalanine;(S)-3-phenyl-2-(pyrazine-2-carboxamido)propionic acid;(S)-3-Phenyl-2-[(pyrazine-2-carbonyl)-amino]-propionic acid;L-Phenylalanine, N-(pyrazinylcarbonyl)-;pyrazine-2-carbonylphenylalanine;L-;Bortezomi;L-Phenylalanine, N-(2-pyrazinylcarbonyl)-;Borte;(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanoic acid;Q-102519;AS-18728;A803186;CS-W020144;EN300-209552;Bortezomib (m4);SCHEMBL535687;N-(Pyrazine-2-carbonyl)-L-phenylalanine;(2S)-3-Phenyl-2-[[(pyrazin-2-yl)carbonyl]amino]propanoic Acid;1093959-75-1;N-(pyrazine-2-yl-carbonyl)-L-phenylalanine;N-pyrazineformyl-L-phenylalanine;9R67B83S2T;(S)-3-Phenyl-2-(((pyrazin-2-yl)carbonyl)amino)propanoic acid;(s)-3-phenyl-2-((pyrazin-2-ylcarbonyl)amino)propanoic acid;AMY1063;MFCD09800536;N-(Pyrazinylcarbonyl)-L-phenylalanine , (+)-;AC-9333;AKOS010373022;P2068;UNII-9R67B83S2T;(s)-3-phenyl-2-(pyrazine-2-carboxamido) propanoic acid;(S)-3-phenyl-2-(pyrazine-2-carboxamido)propanoicacid;DWYZPDHMMZGQAP-NSHDSACASA-N;CHEMBL4557886;DTXSID80567409;(S)-3-Phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoic acid;114457-94-2;DB-298528;DB-032318;(2S)-3-PHENYL-2-(PYRAZIN-2-YLFORMAMIDO)PROPANOIC ACID
CAS番号：	114457-94-2
分子式：	C₁₄H₁₃N₃O₃
分子量：	271.271322965622

品名:

(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanoic acid

英語別名:

(S)-3-Phenyl-2-(pyrazine-2-carboxamido)propanoic acid;N-(Pyrazinylcarbonyl)-L-phenylalanine;(S)-3-PHENYL-2-[(PYRAZIN-2-YLCARBONYL)AMINO] PROPANOIC ACID;(S)-3-Phenyl-2-[[(pyrazin-2-yl)carbonyl]amino]propanoic acid;L-Phenylalanine,N-(2-pyrazinylcarbonyl)-;N-(2-Pyrazinylcarbonyl)-L-phenylalanine;N-Pyrazinylcarbonyl-;N-Pyrazinylcarbonyl-L-phenylalanine;N-PYRAZINYLCARBONYLPHENYLALANINE;(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoic acid;Bortezomib INT B;Bortezomib impurity B;Bortezomib Impurity 36;Bortezomib Acid Impurity;N-(2-pyrazinylcarbonyl)-;Bortezomib Intermediate 2;(pyrazine-2-carbonyl)-L-phenylalanine;(S)-3-phenyl-2-(pyrazine-2-carboxamido)propionic acid;(S)-3-Phenyl-2-[(pyrazine-2-carbonyl)-amino]-propionic acid;L-Phenylalanine, N-(pyrazinylcarbonyl)-;pyrazine-2-carbonylphenylalanine;L-;Bortezomi;L-Phenylalanine, N-(2-pyrazinylcarbonyl)-;Borte;(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanoic acid;Q-102519;AS-18728;A803186;CS-W020144;EN300-209552;Bortezomib (m4);SCHEMBL535687;N-(Pyrazine-2-carbonyl)-L-phenylalanine;(2S)-3-Phenyl-2-[[(pyrazin-2-yl)carbonyl]amino]propanoic Acid;1093959-75-1;N-(pyrazine-2-yl-carbonyl)-L-phenylalanine;N-pyrazineformyl-L-phenylalanine;9R67B83S2T;(S)-3-Phenyl-2-(((pyrazin-2-yl)carbonyl)amino)propanoic acid;(s)-3-phenyl-2-((pyrazin-2-ylcarbonyl)amino)propanoic acid;AMY1063;MFCD09800536;N-(Pyrazinylcarbonyl)-L-phenylalanine , (+)-;AC-9333;AKOS010373022;P2068;UNII-9R67B83S2T;(s)-3-phenyl-2-(pyrazine-2-carboxamido) propanoic acid;(S)-3-phenyl-2-(pyrazine-2-carboxamido)propanoicacid;DWYZPDHMMZGQAP-NSHDSACASA-N;CHEMBL4557886;DTXSID80567409;(S)-3-Phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoic acid;114457-94-2;DB-298528;DB-032318;(2S)-3-PHENYL-2-(PYRAZIN-2-YLFORMAMIDO)PROPANOIC ACID

CAS番号：

114457-94-2

分子式：

C₁₄H₁₃N₃O₃

分子量：

271.271322965622

Technical Support：Kuujia

製品分類

関連製品

アクセス

Twitter

Mobile Website